What is the address of MEDICAZU CONSULTING & CONCEPT?

The registered office of MEDICAZU CONSULTING & CONCEPT is located at Spruitjeshof 2, 9472 Denderleeuw.

Is MEDICAZU CONSULTING & CONCEPT still active?

Yes. According to the CBE (31 October 2026) MEDICAZU CONSULTING & CONCEPT is active, legal situation “Normale toestand”, started on 7 November 2013.

Is MEDICAZU CONSULTING & CONCEPT registered on Peppol?

Yes, MEDICAZU CONSULTING & CONCEPT is registered on the Peppol network with ID 0208:0541715405.

What is the enterprise number of MEDICAZU CONSULTING & CONCEPT?

The enterprise number of MEDICAZU CONSULTING & CONCEPT is BE0541715405.

When was MEDICAZU CONSULTING & CONCEPT founded?

MEDICAZU CONSULTING & CONCEPT was founded on 7 November 2013.

Who are the directors of MEDICAZU CONSULTING & CONCEPT?

According to the 2025 annual accounts, the directors of MEDICAZU CONSULTING & CONCEPT are: Sebastiaan Favoreel.

Is MEDICAZU CONSULTING & CONCEPT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 November 2013; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICAZU CONSULTING & CONCEPT make in 2025?

MEDICAZU CONSULTING & CONCEPT recorded a loss after taxes of € 1,915 in financial year 2025.

What is the revenue of MEDICAZU CONSULTING & CONCEPT?

As a small company, MEDICAZU CONSULTING & CONCEPT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 54,220.

MEDICAZU CONSULTING & CONCEPT (Private Limited)

Q: What does MEDICAZU CONSULTING & CONCEPT do?

MEDICAZU CONSULTING & CONCEPT is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van public relations en communicatie. Private Limited, started on 7 November 2013, 1 establishment.

Dossier MEDICAZU CONSULTING & CONCEPT, printed on 31 October 2026 from databakkes.be/en/0541715405/medicazu-consulting-concept. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDICAZU CONSULTING & CONCEPT from Denderleeuw, company number BE0541715405, closed financial year 2025 with a result of € -1,915 after tax. For that financial year MEDICAZU CONSULTING & CONCEPT recorded a gross margin of € 54,220 and equity of € 273,676. Compared with financial year 2024, the result moved from € 26,542 to € -1,915. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 23, 2026.

What it is worth Healthy

€ 273,676

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,915

▼ still € 26,542 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19,923

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 273,176.

People and assets in 2025

Vehicles and equipment

€ 7

▼ € 60,818 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 343,359

▼ 16% vs 2024

€ 36,903 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 2,997

▲ € 2,621 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,237

▼ 5% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 167,496 Gross margin 2022: € 167,496 First fiscal year in the series	€ 80,069 Gross margin 2023: € 80,069 ▼ 52% vs 2022 (€ 167,496) Unfavourable step	€ 80,973 Gross margin 2024: € 80,973 ▲ 1% vs 2023 (€ 80,069) Favourable step	€ 54,220 Gross margin 2025: € 54,220 ▼ 33% vs 2024 (€ 80,973) Unfavourable step	▼ 33%
Profit after taxes	€ 94,955 Profit after taxes 2022: € 94,955 First fiscal year in the series	€ -10,909 Profit after taxes 2023: € -10,909 ▼ € 105,864 vs 2022 (€ 94,955) Unfavourable step	€ 26,542 Profit after taxes 2024: € 26,542 ▲ € 37,451 vs 2023 (€ -10,909) Favourable step	€ -1,915 Profit after taxes 2025: € -1,915 ▼ € 28,457 vs 2024 (€ 26,542) Unfavourable step	▼ € 28,457
Equity	€ 406,563 Equity 2022: € 406,563 First fiscal year in the series	€ 366,629 Equity 2023: € 366,629 ▼ 10% vs 2022 (€ 406,563) Unfavourable step	€ 275,591 Equity 2024: € 275,591 ▼ 25% vs 2023 (€ 366,629) Unfavourable step	€ 273,676 Equity 2025: € 273,676 ▼ 1% vs 2024 (€ 275,591) Unfavourable step	▼ 1%
Total debts	€ 207,313 Total debts 2022: € 207,313 First fiscal year in the series	€ 457,257 Total debts 2023: € 457,257 ▲ 121% vs 2022 (€ 207,313) Unfavourable step	€ 507,481 Total debts 2024: € 507,481 ▲ 11% vs 2023 (€ 457,257) Unfavourable step	€ 443,172 Total debts 2025: € 443,172 ▼ 13% vs 2024 (€ 507,481) Favourable step	▼ 13%
Cash	€ 7,221 Cash 2022: € 7,221 First fiscal year in the series	€ 81,940 Cash 2023: € 81,940 ▲ € 74,720 vs 2022 (€ 7,221) Favourable step	€ 21,952 Cash 2024: € 21,952 ▼ 73% vs 2023 (€ 81,940) Unfavourable step	€ 19,923 Cash 2025: € 19,923 ▼ 9% vs 2024 (€ 21,952) Unfavourable step	▼ 9%
Land & buildings	€ 230,384 Land & buildings 2022: € 230,384 First fiscal year in the series	€ 540,770 Land & buildings 2023: € 540,770 ▲ 135% vs 2022 (€ 230,384) Unchanged	€ 556,558 Land & buildings 2024: € 556,558 ▲ 3% vs 2023 (€ 540,770) Unchanged	€ 548,656 Land & buildings 2025: € 548,656 ▼ 1% vs 2024 (€ 556,558) Unchanged	▼ 1%
Retained profit	€ 406,063 Retained profit 2022: € 406,063 First fiscal year in the series	€ 366,129 Retained profit 2023: € 366,129 ▼ 10% vs 2022 (€ 406,063) Unfavourable step	€ 275,091 Retained profit 2024: € 275,091 ▼ 25% vs 2023 (€ 366,129) Unfavourable step	€ 273,176 Retained profit 2025: € 273,176 ▼ 1% vs 2024 (€ 275,091) Unfavourable step	▼ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 29,026 Dividend 2023: € 29,026 Unchanged (€ 0) Unchanged	€ 117,580 Dividend 2024: € 117,580 ▲ € 88,554 vs 2023 (€ 29,026) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 117,580) Unchanged	▼ 100%
Bank debt	€ 143,455 Bank debt 2022: € 143,455 First fiscal year in the series	€ 414,291 Bank debt 2023: € 414,291 ▲ 189% vs 2022 (€ 143,455) Unfavourable step	€ 408,251 Bank debt 2024: € 408,251 ▼ 1% vs 2023 (€ 414,291) Favourable step	€ 343,359 Bank debt 2025: € 343,359 ▼ 16% vs 2024 (€ 408,251) Favourable step	▼ 16%
Balance sheet total	€ 613,876 Balance sheet total 2022: € 613,876 First fiscal year in the series	€ 823,886 Balance sheet total 2023: € 823,886 ▲ 34% vs 2022 (€ 613,876) Unchanged	€ 783,072 Balance sheet total 2024: € 783,072 ▼ 5% vs 2023 (€ 823,886) Unchanged	€ 716,848 Balance sheet total 2025: € 716,848 ▼ 8% vs 2024 (€ 783,072) Unchanged	▼ 8%

Key figures of MEDICAZU CONSULTING & CONCEPT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICAZU CONSULTING & CONCEPT?

What happened at MEDICAZU CONSULTING & CONCEPT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 23, 2026 New annual accounts for financial year 2025: loss of € 1,915 (▼ € 28,457 vs 2024). filed late Source: NBB ↗
Dec 11, 2013 New establishment in Denderleeuw. KBO
Nov 7, 2013 Start of the company according to the CBE. KBO

In short

From € 94,955 profit in 2022 to € 1,915 loss in 2025.

Paid € 57,290 in corporate taxes since 2022.

Best year ever: 2022, with € 94,955 profit.

Paid out € 146,606 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sebastiaan Favoreel

MEDICAZU CONSULTING & CONCEPT

Cosmex 50%

Behind MEDICAZU CONSULTING & CONCEPT is Sebastiaan Favoreel. It owns 50% of Cosmex itself.

Directors

According to the 2025 annual accounts

Sebastiaan Favoreel

Director

Also active at: CiGuPhar

Establishments

Establishment units

Physical locations of this company

Registered office

Spruitjeshof 2

9472 Denderleeuw

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0541.715.405

VAT number

BE 0541.715.405

Registered office

Spruitjeshof 2, 9472 Denderleeuw

Names & denominations

MEDICAZU CONSULTING & CONCEPT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 November 2013

Peppol

Active · Active since 26 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Handelsbemiddeling in de niet-gespecialiseerde groothandel

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICAZU CONSULTING & CONCEPT

Warning lights

Financials

What happened to MEDICAZU CONSULTING & CONCEPT?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions